Abstract:Background: Primary aldosteronism (PA) is a secondary form of hypertension resulting from the autonomous hypersecretion of aldosterone. The recognition of PA has an important impact on clinical management, since the choice of therapy is different - surgical for adenoma and medical for hyperplasia. Aim: To evaluate patients with PA in regard to clinical and biochemical factors differentiating between adenoma of adrenal cortex (APA) and idiopathic adrenal hyperplasia (IHA). Methods: We retrospectively analysed 62 patients with PA (33 females, 29 males, mean age 49.3+/-12.5 years, range 26-78) diagnosed in the Department of Hypertension between 1990-2001. In 37 patients (mean age 47.4+/-12.1 years, 22 females, 15 males) APA was diagnosed whereas in the remaining 26 patients (mean age 52.2+/-12.6 years, 14 males, 11 females) IHA was detected. Clinical manifestation, biochemical, serum aldosterone (SA), plasma renin activity (PRA) as well as echocardiographic parameters and blood pressure (BP) levels were evaluated. Diagnostic accuracy of computed tomography (CT) and scintigraphy was also assessed. Results: Mean systolic BP was significantly higher in the patients with APA. Both groups had similar mean diastolic BP. Severe hypertension, resistant to three or more medications, was found in 63.3% of all patients. Muscle weakness was reported by 39.7% of patients, polyuria - by 19%, and polydypsia - by 10.3% of patients. Patients with muscle weakness had higher mean systolic BP level and lower plasma potassium level than patients without this complaint. Symptoms suggesting cardiac arrhythmia were reported by 45% of patients. A normal potassium level was found in 25.8% of all patients. The hypokalemic patients were younger, had shorter known duration of hypertension, higher mean systolic BP level and higher SA concentration than the normokalemic patients. Supine SA levels were significantly higher in the APA group than in the IHA group (50.3+/-29.0 ng% vs 30.5+/-14.7 ng%; p<0.001). The SA/PRA ratio higher than 30:1 was found in all patients. Response to postural test with a rise in SA concentration higher than 30% was observed in 40% patients with APA and in 87.5% patients with IHA (p<0.0001). There was a strong correlation between supine and upright SA level, and systolic and diastolic BP level as well as plasma potassium level. Left ventricular hypertrophy was present in 60% of patients. The differentiation between APA and IHA was possible using CT, scintigraphy or both methods in 75%, 89.2% and 100% of patients, respectively. Conclusions: One quarter of patients with PA were normokalemic. PA should be suspected especially in patients with severe hypertension, resistant to three or more antihypertensive drugs. Changes in SA concentration during the postural tests such as CT and scintigraphy are useful for differentiation between APA and IHA.

Water and Electrolyte Content in Hypertension in the Skin (WHYSKI) in Primary Aldosteronism

Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism among Chinese Population.

A Prospective Observational Study of Factors Affecting the Change in Quality of Life in Patients with Primary Aldosteronism after Treatment.

Prevalence, Subtype Classification, and Outcomes of Treatment of Primary Aldosteronism: A Prospective Study in China

8437 Improved Quality Of Life&Blood Pressure Following Diagnosis And Medical Management Of Primary Aldosteronism (PA) / Georgian Experience

EVALUATION OF CHORIORETINAL VASCULARIZATION WITH OCT AND ANGIO-OCT IN PRIMARY ALDOSTERONISM

Primary Aldosteronism in Chronic Kidney Disease: Blood Pressure Control and Kidney and Cardiovascular Outcomes After Surgical Versus Medical Management

Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor Blockade

Clinical Characteristics of Primary Aldosteronism Screened from Chinese Patients with Hypertension: the China Primary Aldosteronism Prospective Study.

The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism

What We Know about and What Is New in Primary Aldosteronism

Screening for primary aldosteronism in patients with resistant hypertension

Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis

Biomarkers to Guide Medical Therapy in Primary Aldosteronism

Case Report: Primary Aldosteronism and Subclinical Cushing Syndrome in a 49-Year-old Woman with Hypertension Plus Hypokalaemia.

Electrical and Myocardial Remodeling in Primary Aldosteronism

Follow-up Data Analysis of Primary Aldosteronism Patients after Medication Therapy

The Comparison of Clinical Features Between Hypokalemic and Normokalemic Primary Aldosteronism Patients

Tolerability and Efficacy of Long-Term Medical Therapy in Primary Aldosteronism

PS 17-03 ABSTRACT TYPE: ORAL OR POSTER ABSTRACT SUBMISSION NO. PN-2639; THE RELATIONSHIP BETWEEN PARATHYROID HORMONE AND PRIMARY ALDOSTERONISM

Characterizing the Origins of Primary Aldosteronism